Tips for: Solid Oral Dosage Forms

In pharmaceutical manufacturing, capping occurs when the top or bottom layer of a tablet separates partially or completely from the main body during tablet compression. This defect compromises the tablet’s integrity, appearance, and functionality, especially for specialized formulations like Immediate-Release Tablets and Compression-Coated Tablets.
Click to read the full article.

In the pharmaceutical industry, lubricants play a critical role in ensuring smooth tablet manufacturing. They minimize friction during the compression and ejection processes, preventing damage to both the Immediate-Release Tablets and the machinery involved. Proper selection and use of Lubricant in Tablet Manufacturing directly influence tablet quality, weight uniformity, and Tablet Hardness Testing.
Click to read the full article.

Dry Granulation is one of the most critical processes in tablet production, especially when the active pharmaceutical ingredients (APIs) are sensitive to moisture or heat. Unlike wet granulation, this method eliminates the need for liquid binders, making it ideal for creating Immediate-Release Tablets, Compression-Coated Tablets, and Tablets for Suspension.
Click to read the full article.

In modern pharmaceutical manufacturing, tablet coating plays a vital role in ensuring the stability, functionality, and patient compliance of medications. Coatings not only improve the tablet’s appearance but also aid in targeted drug delivery, taste masking, and protection from environmental factors. The various coating types, including Film-Coated Tablets, Sugar-Coated Tablets, Enteric-Coated Tablets, and Layered Tablets, cater to different therapeutic and manufacturing needs.
Click to read the full article.

Rapid dissolution tablets are designed to disintegrate and release their active pharmaceutical ingredients (APIs) quickly in the gastrointestinal tract, ensuring swift therapeutic action. These tablets are commonly used for pain relief, fever reduction, or other conditions where immediate effect is necessary. Achieving rapid dissolution requires careful formulation and manufacturing processes to ensure efficacy and patient satisfaction.
Click to read the full article.

Binder concentration issues refer to problems arising from improper amounts of binding agents used during the granulation process. Binders play a critical role in enhancing granule strength, flowability, and compressibility. However, incorrect binder levels can lead to problems such as poor granule cohesion, excessive hardness, or tablet disintegration failures.
Click to read the full article.

Uniform API distribution in tablet formulations ensures that each dosage contains the correct amount of active pharmaceutical ingredient (API). Inconsistent distribution can lead to dosage variability, reduced therapeutic efficacy, and regulatory non-compliance. Achieving uniformity is particularly challenging when APIs have poor flow properties, low concentrations, or large particle size differences compared to excipients.
Click to read the full article.

API degradation refers to the chemical or physical breakdown of the active pharmaceutical ingredient (API) in a tablet over time. In slow-release tablets, degradation can affect the controlled-release mechanism, reducing efficacy and compromising patient safety. Factors like moisture, heat, pH, and API-excipient interactions often contribute to degradation, making it essential to identify and resolve these issues effectively.
Click to read the full article.

Multilayer tablets are designed to deliver different active pharmaceutical ingredients (APIs) or controlled-release profiles in a single dosage form. However, their layered structure makes them more prone to stability issues, such as delamination, cracking, or incompatibility between layers. Optimizing stability is critical to ensure the performance, safety, and shelf life of multilayer tablets.
Click to read the full article.

Temperature sensitivity in coated tablets refers to the impact of temperature fluctuations on their stability, performance, and appearance. Excessive heat or cold can cause coating defects such as cracking, peeling, or stickiness, and may also degrade the active pharmaceutical ingredients (APIs). Properly managing temperature sensitivity is critical to maintaining tablet efficacy, stability, and compliance with regulatory standards.
Click to read the full article.

Light-induced degradation occurs when exposure to UV or visible light causes the active pharmaceutical ingredients (APIs) or excipients in tablets to break down. This degradation can lead to reduced potency, discoloration, or the formation of harmful byproducts, ultimately compromising the tablet’s efficacy and safety.
Click to read the full article.

Slow-release tablets are designed to release their active pharmaceutical ingredients (APIs) over a prolonged period. High-humidity conditions can compromise their stability, leading to swelling, degradation, or dissolution profile changes. These issues can affect the therapeutic efficacy and shelf life of the tablets, making it essential to implement strategies to stabilize them in humid environments.
Click to read the full article.